InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Donohue James J.. Director active across 1 company, notably Acurx Pharmaceuticals, Inc.. Aggregated, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 6 January 2025. The latest transaction was disclosed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration